Woodmont Investment Counsel LLC acquired a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 18,551 shares of the company's stock, valued at approximately $1,835,000. Woodmont Investment Counsel LLC owned approximately 0.10% of Addus HomeCare as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. Natixis increased its position in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after buying an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its position in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after buying an additional 148 shares during the period. Meeder Asset Management Inc. purchased a new stake in Addus HomeCare in the fourth quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in shares of Addus HomeCare in the fourth quarter valued at approximately $86,000. Institutional investors and hedge funds own 95.35% of the company's stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on ADUS shares. Stephens reaffirmed an "overweight" rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities restated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research note on Friday. Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Macquarie reissued an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Addus HomeCare has an average rating of "Buy" and a consensus price target of $142.57.
Check Out Our Latest Report on Addus HomeCare
Insider Activity
In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president now directly owns 7,796 shares in the company, valued at approximately $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 4.60% of the company's stock.
Addus HomeCare Stock Performance
NASDAQ ADUS traded up $1.04 on Tuesday, hitting $114.05. 214,521 shares of the company's stock were exchanged, compared to its average volume of 170,751. The firm has a market cap of $2.10 billion, a price-to-earnings ratio of 25.74, a P/E/G ratio of 1.61 and a beta of 0.81. The firm's 50-day moving average price is $109.13 and its two-hundred day moving average price is $111.78. Addus HomeCare Corporation has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.74 and a quick ratio of 1.74.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The firm had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the prior year, the company posted $1.21 earnings per share. Addus HomeCare's quarterly revenue was up 20.3% on a year-over-year basis. On average, research analysts expect that Addus HomeCare Corporation will post 4.59 EPS for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.